IQ EQ Fund Management’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.71M Sell
97,158
-27,173
-22% -$1.14M 0.36% 82
2026
Q1
$4M Sell
124,331
-30,279
-20% -$1.12M 0.3% 93
2025
Q4
$6.51M Buy
154,610
+15,501
+11% +$625K 0.45% 69
2025
Q3
$4.78M Buy
139,109
+68,615
+97% +$1.97M 0.32% 94
2025
Q2
$1.91M Buy
70,494
+39,890
+130% +$1.16M 0.17% 148
2025
Q1
$907K Buy
30,604
+12,448
+69% +$474K 0.11% 188
2024
Q4
$719K Buy
18,156
+8,615
+90% +$326K 0.08% 223
2024
Q3
$325K Buy
+9,541
New +$268K 0.03% 283

Other funds holding VCYT

IQ EQ Fund Management's VCYT Position: Q2 2026 in Review

IQ EQ Fund Management reduced its Veracyte (VCYT) stake by 22% in Q2 2026, selling an estimated $1.14M and leaving 97,158 shares worth $5.71M. The position accounts for 0.36% of the portfolio, ranked #82.

IQ EQ Fund Management first reported a position in VCYT in Q3 2024 and has held it in 8 quarters since. The position peaked at $6.51M in Q4 2025. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • IQ EQ Fund Management held 97,158 shares of Veracyte worth $5.71M as of Q2 2026.
  • IQ EQ Fund Management sold 27,173 Veracyte shares in Q2 2026, an estimated $1.14M.
  • Veracyte made up 0.36% of IQ EQ Fund Management's portfolio in Q2 2026, its #82 holding.
  • IQ EQ Fund Management first reported a position in Veracyte in Q3 2024 and has held it in 8 quarters since.
  • IQ EQ Fund Management's Veracyte position peaked at $6.51M in Q4 2025.
  • 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on IQ EQ Fund Management's 13F filing for Q2 2026, filed 31 Jul 2026.